Overview

Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment

Status:
Completed

Trial end date:
2020-09-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to test the safety of gemcitabine and oxaliplatin regimen and to see its effects on sorafenib treatment failed hepatocellular carcinoma patients.

Phase:

Phase 2

Details

Lead Sponsor:

Yonsei University

Treatments:

Gemcitabine
Oxaliplatin